| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 313.87B | 297.66B | 324.51B | 356.34B | 343.27B | 365.27B |
| Gross Profit | 155.46B | 155.22B | 158.65B | 163.68B | 173.02B | 192.16B |
| EBITDA | 40.42B | 63.42B | 48.25B | 25.68B | 65.43B | 77.97B |
| Net Income | 18.60B | 29.62B | 24.41B | 14.91B | 49.26B | 51.01B |
Balance Sheet | ||||||
| Total Assets | 402.48B | 438.02B | 416.16B | 411.93B | 400.59B | 380.90B |
| Cash, Cash Equivalents and Short-Term Investments | 231.72B | 276.05B | 247.76B | 225.90B | 193.50B | 163.09B |
| Total Debt | 3.78B | 0.00 | 1.54B | 2.15B | 2.17B | 4.34B |
| Total Liabilities | 73.24B | 88.79B | 79.79B | 94.80B | 83.32B | 96.47B |
| Stockholders Equity | 328.94B | 348.88B | 336.06B | 316.87B | 317.04B | 284.24B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 45.34B | 31.91B | 42.95B | 6.55B | 22.08B |
| Operating Cash Flow | 0.00 | 51.58B | 42.78B | 52.24B | 12.23B | 27.57B |
| Investing Cash Flow | 0.00 | -6.21B | -15.11B | -13.21B | 27.60B | -8.12B |
| Financing Cash Flow | 0.00 | -18.43B | -6.60B | -14.79B | -15.52B | -9.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥511.33B | 6.94 | ― | 2.49% | 6.31% | 10.31% | |
71 Outperform | ¥8.39T | 38.98 | 13.46% | 1.17% | 98.56% | 52.21% | |
70 Outperform | ¥2.64T | 26.21 | 17.57% | 0.84% | 17.10% | 33.90% | |
65 Neutral | ¥1.34T | 25.65 | 26.91% | 1.17% | 15.19% | 12.65% | |
63 Neutral | ¥995.95B | 30.48 | 6.70% | 1.80% | -8.27% | 21.14% | |
61 Neutral | ¥466.32B | 11.51 | -3.66% | 2.12% | 13.66% | -113.12% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |